Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.

Valérie Andriantsoanirina (1) , Arsène Ratsimbasoa (2) , Christiane Bouchier (3) , Martial Jahevitra (1) , Stéphane Rabearimanana (1) , Rogelin Radrianjafy (1) , Voahangy Andrianaranjaka (1) , Tantely Randriantsoa (1) , Marie Ange Rason (1) , Magali Tichit (3) , Léon Paul Rabarijaona (4) , Odile Mercereau-Puijalon (5) , Rémy Durand (6) , Didier Ménard (1, 5)

1 Institut Pasteur de Madagascar
2 Departement de Santé Publique
3 Génopole
4 Section Survie de l'Enfant
5 Immunologie moléculaire des parasites
6 Laboratoire de Parasitologie-Mycologie

The aim of this study was to provide the first comprehensive spatiotemporal picture of Plasmodium falciparum resistance in various geographic areas in Madagascar. Additional data about the antimalarial resistance in the neighboring islands of the Comoros archipelago were also collected. We assessed the prevalence of pfcrt, pfmdr-1, pfdhfr, and pfdhps mutations and the pfmdr-1 gene copy number in 1,596 P. falciparum isolates collected in 26 health centers (20 in Madagascar and 6 in the Comoros Islands) from 2006 to 2008. The in vitro responses to a panel of drugs by 373 of the parasite isolates were determined. The results showed (i) unusual profiles of chloroquine susceptibility in Madagascar, (ii) a rapid rise in the frequency of parasites with both the pfdhfr and the pfdhps mutations, (iii) the alarming emergence of the single pfdhfr 164L genotype, and (iv) the progressive loss of the most susceptible isolates to artemisinin derivatives. In the context of the implementation of the new national policy for the fight against malaria, continued surveillance for the detection of P. falciparum resistance in the future is required.

Domains: Infectious diseases

Valérie Andriantsoanirina, Arsène Ratsimbasoa, Christiane Bouchier, Martial Jahevitra, Stéphane Rabearimanana, et al.. Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.. Antimicrobial Agents and Chemotherapy, 2009, 53 (11), pp.4588-97. ⟨10.1128/AAC.00610-09⟩. ⟨pasteur-00741124⟩